LIMS Advisory Board
The LIMS Advisory Board provides strategic advice on the Institute’s research agenda.
Professor Marilyn Anderson AO
Professor Anderson AO is Professor of Biochemistry at La Trobe University and the Chief Scientist of Hexima Ltd.
She is a Fellow of the Australian Academy of Science and the Australian Academy of Technological Sciences and Engineering. She was awarded the Lemberg Medal from the Australian Society of Biochemistry and Molecular Biology in 2014.
Professor Matthias Ernst
Professor Matthias Ernst is the Head of the School of Cancer Medicine at La Trobe University and the Scientific Director of the Olivia Newton-John Cancer Research Institute.
He obtained his PhD from the ETH Zurich, Switzerland and is a member of the Ludwig Institute for Cancer Research and a Principal Research Fellow of the NHMRC.
Professor Andrew Hill
He is currently president of the International Society of Extracellular Vesicles. He was awarded the 2010 Merck Research Excellence Medal from the Australian Society for Biochemistry and Molecular Biology.
Professor Keith Nugent
Professor Nugent is Deputy Vice-Chancellor (Research) at La Trobe University.
He is a Fellow of the Australian Academy of Science, the Australian Institute of Physics and the American Physical Society. He is a recipient of the 2004 Victoria Prize, the Pawsey Medal from the Australian Academy of Science and the Boas Medal from the Australian Institute of Physics.
Professor Andrew Peele
Professor Peele is Director of the Australian Synchrotron.
He is Professor of Physics at La Trobe University and was seconded to the Australian Synchrotron as Head of Science in 2011. He is a Principal Investigator in the ARC Centre of Excellence for Advanced Molecular Imaging and has published over 100 research papers.
Professor Robert Pike
Professor Pike is Pro Vice-Chancellor of the College of Science, Health and Engineering.
He has over 10 years’ experience in academic and research leadership roles. Professor Pike is a biochemist specialising in enzymes. He has published over 100 research papers and supervised over 20 PhD students to completion.
Dr Tony Radford AO
Dr Radford AO is a Director of Ellume Ltd and ASX listed Genetic Signatures Ltd.
He was previously Director of Nucleus Networks and CEO of ASX listed Cellestis, from its founding until its acquisition by QIAGEN NV in 2011. For his contributions to tuberculosis diagnosis and enterprise he received the Clunies Ross Award for application of technology, and is a Distinguished Alumnus of La Trobe University.
Dr Nick Samaras
Dr Samaras is Director of AGRF Pty Ltd and MuriGen Therapeutics, Chairman of ASX listed Genetic Signatures Ltd and Adjunct Professor at La Trobe University.
He has over 25 years’ experience in the science industry, and has worked in senior roles with global life science companies including Applied Biosystems and Perkin Elmer.